Ragab AA et al. |
Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. |
2002 |
Am. J. Physiol., Cell Physiol. |
pmid:12176725
|
Whyte MP et al. |
Osteoprotegerin deficiency and juvenile Paget's disease. |
2002 |
N. Engl. J. Med. |
pmid:12124406
|
Krane SM |
Genetic control of bone remodeling--insights from a rare disease. |
2002 |
N. Engl. J. Med. |
pmid:12124412
|
Ziolkowska M et al. |
High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment. |
2002 |
Arthritis Rheum. |
pmid:12124857
|
Campagnuolo G et al. |
Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis. |
2002 |
Arthritis Rheum. |
pmid:12124878
|
Sakata M et al. |
Osteoprotegerin levels increased by interleukin-1beta in human periodontal ligament cells are suppressed through prostaglandin E(2) synthesized de novo. |
2002 |
Cytokine |
pmid:12126649
|
Petersson M et al. |
Oxytocin stimulates proliferation of human osteoblast-like cells. |
2002 |
Peptides |
pmid:12126740
|
Cundy T et al. |
A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. |
2002 |
Hum. Mol. Genet. |
pmid:12189164
|
Williamson E et al. |
Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction. |
2002 |
J. Immunol. |
pmid:12244151
|
Lee SK et al. |
1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts. |
2002 |
J. Immunol. |
pmid:12193704
|
Ferrer Cañabate J et al. |
[Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?]. |
2002 |
An Med Interna |
pmid:12244784
|
Chen XW et al. |
Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:12150965
|
Katagiri T and Takahashi N |
Regulatory mechanisms of osteoblast and osteoclast differentiation. |
2002 |
Oral Dis |
pmid:12108759
|
Lee SK and Lorenzo JA |
Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. |
2002 |
Bone |
pmid:12110442
|
Shioi A et al. |
Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. |
2002 |
Circ. Res. |
pmid:12114316
|
Lipton A et al. |
Serum osteoprotegerin levels in healthy controls and cancer patients. |
2002 |
Clin. Cancer Res. |
pmid:12114435
|
Fujita T et al. |
SPARC stimulates the synthesis of OPG/OCIF, MMP-2 and DNA in human periodontal ligament cells. |
2002 |
J. Oral Pathol. Med. |
pmid:12201246
|
Juji T et al. |
A novel therapeutic vaccine approach, targeting RANKL, prevents bone destruction in bone-related disorders. |
2002 |
J. Bone Miner. Metab. |
pmid:12203031
|
Grisar J et al. |
Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. |
2002 |
J. Rheumatol. |
pmid:12136902
|
Hofbauer LC et al. |
Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells. |
2002 |
Eur. J. Endocrinol. |
pmid:12153751
|
Mundy GR |
Metastasis to bone: causes, consequences and therapeutic opportunities. |
2002 |
Nat. Rev. Cancer |
pmid:12154351
|
Lorget F et al. |
Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:12163011
|
Ulrich-Vinther M et al. |
Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. |
2002 |
J Bone Joint Surg Am |
pmid:12177271
|
Ohmori H et al. |
Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis. |
2002 |
J. Hum. Genet. |
pmid:12181640
|
Udagawa N and Takahashi N |
[Possible role of receptor activator of NF-kappa B ligand(RANKL) in osteoclast differentiation and function]. |
2002 |
Nippon Rinsho |
pmid:11979968
|
Tsuda E |
[Osteoclastogenesis inhibitory factor (OCIF)/OPG (a novel therapeutic candidate for the treatment of metabolic bone diseases)]. |
2002 |
Nippon Rinsho |
pmid:11979969
|
Koshihara Y |
[Recent progress of bone cell culture system (review)]. |
2002 |
Nippon Rinsho |
pmid:11979973
|
Khosla S et al. |
Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:11932280
|
Kanematsu M et al. |
Vector-averaged gravity regulates gene expression of receptor activator of NF-kappaB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP/protein kinase A pathway. |
2002 |
Bone |
pmid:11934645
|
Li X et al. |
Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. |
2002 |
Bone |
pmid:11934647
|
Jiang Y et al. |
Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. |
2002 |
Infect. Immun. |
pmid:12011008
|
Granchi D et al. |
Bone cement extracts modulate the osteoprotegerin/osteoprotegerin-ligand expression in MG63 osteoblast-like cells. |
2002 |
Biomaterials |
pmid:12013183
|
Li X et al. |
Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo. |
2002 |
Prostaglandins Other Lipid Mediat. |
pmid:12013525
|
Bosshart H |
Expression of survival receptors in Hodgkin disease cell lines. |
2002 |
Blood |
pmid:12001908
|
Ono K et al. |
Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines. |
2002 |
J. Bone Miner. Res. |
pmid:12009007
|
Iida-Klein A et al. |
Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. |
2002 |
J. Bone Miner. Res. |
pmid:12009011
|
Jain RG and Lenhard JM |
Select HIV protease inhibitors alter bone and fat metabolism ex vivo. |
2002 |
J. Biol. Chem. |
pmid:11937496
|
Ariyasu T et al. |
Trehalose augments osteoprotegerin production in the FHs74Int human intestinal epithelial cell line. |
2002 |
In Vitro Cell. Dev. Biol. Anim. |
pmid:11963965
|
Bateman TA and Countryman S |
Osteoprotegerin and bone loss associated with spaceflight. |
2002 |
Drug Discov. Today |
pmid:11965392
|
Price PA et al. |
Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. |
2002 |
J. Bone Miner. Res. |
pmid:12096831
|
Xing L et al. |
NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. |
2002 |
J. Bone Miner. Res. |
pmid:12096833
|
Zou W and Bar-Shavit Z |
Dual modulation of osteoclast differentiation by lipopolysaccharide. |
2002 |
J. Bone Miner. Res. |
pmid:12096834
|
Koyama H et al. |
Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. |
2002 |
J. Bone Miner. Res. |
pmid:12096835
|
Langdahl BL et al. |
Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. |
2002 |
J. Bone Miner. Res. |
pmid:12096838
|
Zhang J et al. |
Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice. |
2002 |
J. Bone Miner. Res. |
pmid:12096839
|
Ueland T et al. |
Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: a double-blind, randomized, placebo-controlled study. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:12050246
|
Sasaki N et al. |
Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis. |
2002 |
Bone |
pmid:12052453
|
Palenzuela L et al. |
Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene. |
2002 |
J. Med. Genet. |
pmid:12362049
|
Fu Q et al. |
Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. |
2002 |
J. Biol. Chem. |
pmid:12364326
|
Rogers A et al. |
Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:12364420
|
Romas E et al. |
Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. |
2002 |
Am. J. Pathol. |
pmid:12368214
|
Standal T et al. |
Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells. |
2002 |
Blood |
pmid:12351414
|
Yang SY et al. |
Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. |
2002 |
Arthritis Rheum. |
pmid:12355500
|
Suda T et al. |
[Merger of bone biology and immunology]. |
2002 |
Tanpakushitsu Kakusan Koso |
pmid:12385106
|
Biskobing DM et al. |
Novel therapeutic options for osteoporosis. |
2002 |
Curr Opin Rheumatol |
pmid:12118183
|
Nagasawa T et al. |
LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. |
2002 |
Clin. Exp. Immunol. |
pmid:12390325
|
Mizukami J et al. |
Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. |
2002 |
Mol. Cell. Biol. |
pmid:11809792
|
Wynne F et al. |
Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population. |
2002 |
Calcif. Tissue Int. |
pmid:12073153
|
Lubberts E et al. |
Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis. |
2002 |
Arthritis Rheum. |
pmid:12428250
|
Crotti TN et al. |
Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. |
2002 |
Ann. Rheum. Dis. |
pmid:12429533
|
Hofbauer LC and Schoppet M |
Osteoprotegerin deficiency and juvenile Paget's disease. |
2002 |
N. Engl. J. Med. |
pmid:12432053
|
Jono S et al. |
Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. |
2002 |
Circulation |
pmid:12208791
|
Roodman GD |
Role of the bone marrow microenvironment in multiple myeloma. |
2002 |
J. Bone Miner. Res. |
pmid:12412796
|
Hegedus D et al. |
Decreased bone density, elevated serum osteoprotegerin, and beta-cross-laps in Wilson disease. |
2002 |
J. Bone Miner. Res. |
pmid:12412803
|
Zhao S et al. |
MLO-Y4 osteocyte-like cells support osteoclast formation and activation. |
2002 |
J. Bone Miner. Res. |
pmid:12412815
|
Hu Y and Yu S |
Gene expression of osteoprotegerin and osteoclast differentiation factor in giant cell tumor. |
2002 |
Zhonghua Bing Li Xue Za Zhi |
pmid:12419159
|
Sandor M et al. |
A novel polyethylene depot device for the study of PLGA and P(FASA) microspheres in vitro and in vivo. |
2002 |
Biomaterials |
pmid:12219832
|
Shiotani A et al. |
Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin. |
2002 |
Anat. Rec. |
pmid:12221720
|
Cremer I et al. |
Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. |
2002 |
Blood |
pmid:12393586
|
Giuliani N et al. |
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. |
2002 |
Blood |
pmid:12393684
|
Liao EY et al. |
Comparison of the effects of 17beta-E2 and progesterone on the expression of osteoprotegerin in normal human osteoblast-like cells. |
2002 |
J. Endocrinol. Invest. |
pmid:12398237
|
Takahashi E et al. |
High extracellular calcium affects osteoclastogenesis in mouse bone marrow cell culture. |
2002 |
J. Med. Dent. Sci. |
pmid:12641381
|
Stajszczyk M |
[Role of receptor activator of nuclear factor kappa B (RANK), its ligand (RANK-L) and osteoprotegerin (OPG) in bone metabolism]. |
2002 |
Pol. Arch. Med. Wewn. |
pmid:12600190
|
Fahrleitner A et al. |
Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. |
2002 |
Wien. Klin. Wochenschr. |
pmid:12602117
|
Theill LE et al. |
RANK-L and RANK: T cells, bone loss, and mammalian evolution. |
2002 |
Annu. Rev. Immunol. |
pmid:11861618
|
Wise GE et al. |
Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implications for tooth eruption. |
2002 |
Arch. Oral Biol. |
pmid:11839361
|
Faucheux C et al. |
Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone. |
2002 |
J. Bone Miner. Res. |
pmid:11874237
|
Kazama JJ et al. |
Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. |
2002 |
Am. J. Kidney Dis. |
pmid:11877571
|
Haas M et al. |
Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. |
2002 |
Am. J. Kidney Dis. |
pmid:11877577
|
Goater JJ et al. |
Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. |
2002 |
J. Orthop. Res. |
pmid:11918293
|
Kazama JJ et al. |
Circulating osteoprotegerin is not removed through haemodialysis membrane. |
2002 |
Nephrol. Dial. Transplant. |
pmid:12271009
|
Roux S et al. |
RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma. |
2002 |
Br. J. Haematol. |
pmid:11918537
|
Lee SW et al. |
TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB. |
2002 |
J. Biochem. Mol. Biol. |
pmid:12296995
|
Oshiro T et al. |
Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. |
2002 |
Anat. Rec. |
pmid:11920384
|
Redlich K et al. |
Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. |
2002 |
Arthritis Rheum. |
pmid:11920416
|
Cho CH and Nuttall ME |
Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases. |
2002 |
Expert Opin. Ther. Targets |
pmid:12472380
|
Hasegawa T et al. |
Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells. |
2002 |
J. Periodont. Res. |
pmid:12472833
|
Yamashita T et al. |
Double mutations in klotho and osteoprotegerin gene loci rescued osteopetrotic phenotype. |
2002 |
Endocrinology |
pmid:12446599
|
Yang X et al. |
Protein Kinase C is a mediator of the synthesis and secretion of osteoprotegerin in osteoblast-like cells. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:11779130
|
Nosaka K et al. |
Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells. |
2002 |
Blood |
pmid:11781248
|
Takayanagi H |
[Cross-talk between immune and skeletal systems]. |
2002 |
Nippon Rinsho |
pmid:12510352
|
Mochizuki S et al. |
Osteoclastogenesis inhibitory factor/osteoprotegerin ameliorates the decrease in both bone mineral density and bone strength in immobilized rats. |
2002 |
J. Bone Miner. Metab. |
pmid:11810411
|
Childs LM et al. |
In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. |
2002 |
J. Bone Miner. Res. |
pmid:11811549
|
Holloway WR et al. |
Leptin inhibits osteoclast generation. |
2002 |
J. Bone Miner. Res. |
pmid:11811550
|
Coen G et al. |
Serum osteoprotegerin and renal osteodystrophy. |
2002 |
Nephrol. Dial. Transplant. |
pmid:11812872
|
Gravallese EM |
Bone destruction in arthritis. |
2002 |
Ann. Rheum. Dis. |
pmid:12379632
|
Spyrou P et al. |
Cytokine release by osteoblast-like cells cultured on implant discs of varying alloy compositions. |
2002 |
Clin Oral Implants Res |
pmid:12519337
|
Berenson JR |
Advances in the biology and treatment of myeloma bone disease. |
2002 |
Semin. Oncol. |
pmid:12520479
|
Woo KM et al. |
Osteoprotegerin is present on the membrane of osteoclasts isolated from mouse long bones. |
2002 |
Exp. Mol. Med. |
pmid:12526098
|
Bengtsson AK and Ryan EJ |
Immune function of the decoy receptor osteoprotegerin. |
2002 |
Crit. Rev. Immunol. |
pmid:12498383
|